HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Pulmonary Cancer

Pulmonary Cancer

Pulmonary cancer, commonly known as lung cancer, remains one of the most prevalent and lethal forms of cancer worldwide. Research efforts in this field are multifaceted, aiming to understand its intricate biology, improve early detection methods, and develop more effective treatments. From exploring the role of genetic mutations to investigating environmental factors such as smoking and air pollution, scientists strive to unravel the complexities underlying pulmonary cancer. Innovative approaches like immunotherapy and targeted therapies offer promising avenues for personalized treatment, while advancements in imaging techniques enhance diagnostic accuracy. Collaboration between researchers, clinicians, and patients drives progress in this challenging yet vital area of cancer research, with the ultimate goal of improving outcomes and quality of life for those affected by pulmonary cancer.

Committee Members
Committee Member - Jianhua Luo

Jianhua Luo

University of Pittsburgh School of Medicine, United States
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Committee Member - Yan Leyfman

Yan Leyfman

NYP- Meyer Cancer Center, United States

Submit your abstract Today

YouTube
WhatsAppWhatsApp